| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1986.01800110015003 |
| P698 | PubMed publication ID | 3767595 |
| P2093 | author name string | Breier A | |
| Heninger GR | |||
| Charney DS | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | agoraphobia | Q174589 |
| P304 | page(s) | 1029-1036 | |
| P577 | publication date | 1986-11-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness | |
| P478 | volume | 43 |
| Q80072870 | A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder |
| Q34437320 | A neuro-evolutionary approach to the anxiety disorders |
| Q51166773 | A pilot study of panic attacks in a child and adolescent psychiatric population. |
| Q41380471 | A risk-benefit assessment of buspirone in the treatment of anxiety disorders |
| Q37689653 | Agoraphobia: a review of the diagnostic classificatory position and criteria |
| Q37915749 | Alcoholism and panic disorder: is the comorbidity more than coincidence? |
| Q44525657 | Alcoholism in 274 patients with panic disorder in Spain, one of the main producers of wine worldwide |
| Q37957090 | Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition |
| Q30461432 | Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction |
| Q51680689 | Association between estrus cycle-related changes in respiration and estrus cycle-related aggression in outbred female Wistar rats. |
| Q33926801 | Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice |
| Q35336623 | Benzodiazepines. Depressants or antidepressants? |
| Q34529962 | Caffeine abstention in the management of anxiety disorders |
| Q41233168 | Caffeine and its effect on persons with mental disorders |
| Q53312788 | Characteristics of women seeking treatment for premenstrual syndrome in Taiwan. |
| Q52067183 | Characteristics of women seeking treatment for premenstrual syndrome. |
| Q67740890 | Chest pain and breathlessness: Relationship to psychiatric illness |
| Q34032724 | Clinical features of obsessive-compulsive disorder |
| Q28343088 | Cocaine-Associated Panic Attacks in Methadone-Maintained Patients |
| Q36237747 | Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects |
| Q71437040 | Comorbidity of anxiety disorders and hypochondriasis considering different diagnostic systems |
| Q34093719 | Comorbidity of mood and anxiety disorders |
| Q47231269 | Cultural aspects of morbid fears in Qatari women. |
| Q47769841 | Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic patients: toward a rapprochement of European and US views |
| Q44214676 | Depression and anxiety symptoms in relation to anthropometry and metabolism in men. |
| Q22305826 | Diagnosis and Treatment of Agoraphobia with Panic Disorder |
| Q44625574 | Distinguishing generalized anxiety disorder, panic disorder, and mixed anxiety states in older treatment-seeking adults |
| Q73916518 | Effect of alcoholism on the incidence of lactate-induced panic attacks |
| Q43751940 | Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin |
| Q41113725 | Effects of age and alcoholism on the prevalence of panic disorder |
| Q51205015 | Effects of yohimbine in obsessive compulsive disorder. |
| Q27026213 | Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks |
| Q60641815 | Generalizability and correlates of clinically derived panic subtypes in the population |
| Q51176180 | History of separation anxiety in patients with panic disorder and depression and normal controls. |
| Q41056587 | Is early separation anxiety a risk factor for adult panic disorder?: a critical review |
| Q52018243 | Is early separation anxiety a specific precursor of panic disorder–agoraphobia? a community study |
| Q50998526 | Lifetime co-morbidity of panic attacks and major depression in a population-based study: age of onset. |
| Q30431992 | Menstrual cycle-related exacerbation of disease |
| Q51135714 | Mood swings in patients with panic disorder. |
| Q43931023 | Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin |
| Q44473307 | Neurosteroid secretion in panic disorder |
| Q42277099 | Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine |
| Q80422682 | Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase |
| Q35900192 | Panic control treatment and its applications |
| Q36859502 | Panic disorder after the end of chronic alcohol abuse: a report of 2 cases |
| Q58829024 | Panic disorder — acceptance of the diagnostic entity and treatment modalities preferred by German health professionals |
| Q36127525 | Panic disorder. Recognizing and managing the 'real thing' |
| Q48573546 | Panic patients in the non-panic state: physiological and cognitive dysfunction |
| Q34114646 | Panic, hyperventilation and perpetuation of anxiety |
| Q41261205 | Persistent sensitization of clonidine-induced hypokinesia following one exposure to a stressor: possible relevance to panic disorder and its treatment |
| Q43528489 | Personality disorder comorbidity in panic disorder patients with or without current major depression |
| Q33833036 | Premenstrual distress predicts panic-relevant responding to a CO2 challenge among young adult females |
| Q57820500 | Premenstrual exacerbation and suicidal behavior in patients with panic disorder |
| Q51942607 | Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. |
| Q77419879 | Premenstrual syndrome |
| Q72697281 | Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders |
| Q52052261 | Relationship of social phobia with other psychiatric illness |
| Q51095992 | Reliability of the 35% carbon dioxide panic provocation challenge. |
| Q51950959 | Residual symptoms and comorbidity in panic disorder. |
| Q37319814 | Separation anxiety disorder in childhood as a risk factor for future mental illness |
| Q41659205 | Specificity of substance use in anxiety-disordered subjects |
| Q51979218 | Suicidality in panic disorder: a comparison with schizophrenic, depressed, and other anxiety disorder outpatients. |
| Q35951051 | The development of agoraphobia is associated with the symptoms and location of a patient's first panic attack |
| Q44488243 | The effects of female reproductive hormones in generalized social anxiety disorder |
| Q74739722 | The incidence and influence of early traumatic life events in patients with panic disorder: a comparison with other psychiatric outpatients |
| Q35014958 | The panic-agoraphobic spectrum: development, description, and clinical significance |
| Q40869797 | The relationship of attributional style to agoraphobia severity, depression, and treatment outcome |
| Q51189609 | The relationship of panic attacks to autonomically labile generalized anxiety |
| Q36392669 | The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge |
| Q39120929 | The role of perceived control over anxiety in prospective symptom reports across the menstrual cycle |
| Q38679854 | The utility of the panic disorder concept |
| Q35274922 | Theoretical and therapeutic considerations for the anxiety disorders |
| Q37216689 | Validation criteria for panic disorder as a nosological entity |
| Q53379267 | What treatments do patients with panic disorder and agoraphobia get? |
Search more.